trial · primary record
Dose-escalated adaptive radiotherapy
Small Cell Lung Cancer
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 31 |
| Primary completion | 2028-03 |
| Primary endpoint | Local failure rate |
| Registry ID | NCT04952480 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:51.294Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04952480
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.